OTC Markets EXMKT - Delayed Quote USD

Isracann Biosciences Inc. (ISCNF)

Compare
0.0001 0.0000 (0.00%)
As of October 21 at 4:00 PM EDT. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ajay Singh Kaila Interim Chief Executive Officer -- -- --

Isracann Biosciences Inc.

595 Burrard Street
Suite 1600
Vancouver, BC V7X 1L3
Canada
604-394-2551 https://www.isracann.com
Sector:?
Healthcare

Description

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

Corporate Governance

Isracann Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 14, 2022 at 12:00 AM UTC

D: Additional Forms

October 17, 2019 at 12:00 AM UTC

Dividend Date

Related Tickers